In summary, all three B7-H3 CAR T cells showed initial antitumor activity in orthotopic PDAC models; however, Y111 CAR T cells provided superior, long-lasting tumor control, minimal toxicity, and the greatest survival benefit. Here, CD276 is linked to neoplasm.